179 related articles for article (PubMed ID: 12196890)
21. Paraneoplastic pemphigus: report of a case.
Izaki S; Yoshizawa Y; Hashimoto T; Korman NJ; Kitamura K; Hamamatsu Y; Ohashi N; Ogasa S
J Dermatol; 1996 Jun; 23(6):397-404. PubMed ID: 8708152
[TBL] [Abstract][Full Text] [Related]
22. Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris.
Miltenyi Z; Toth J; Gonda A; Tar I; Remenyik E; Illes A
Pathol Oncol Res; 2009 Sep; 15(3):375-81. PubMed ID: 19067241
[TBL] [Abstract][Full Text] [Related]
23. Retroperitoneal reticulum cell sarcoma: a cause of paraneoplastic pemphigus.
Berg WA; Fishman EK; Anhalt GJ
South Med J; 1993 Feb; 86(2):215-7. PubMed ID: 8434295
[TBL] [Abstract][Full Text] [Related]
24. Paraneoplastic pemphigus as the first manifestation of follicular dendritic cell sarcoma.
Liu KL; Shen JL; Yang CS; Chen YJ
J Dtsch Dermatol Ges; 2014 Jan; 12(1):68-71. PubMed ID: 24119156
[No Abstract] [Full Text] [Related]
25. Paraneoplastic pemphigus appearing as bullous pemphigoid-like eruption after palliative radiation therapy.
Fried R; Lynfield Y; Vitale P; Anhalt G
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 2):815-7. PubMed ID: 7691907
[TBL] [Abstract][Full Text] [Related]
26. [Paraneoplastic pemphigus revealing dendritic cell sarcoma originating from Castleman's disease of the neck].
Gironet N; De Muret A; Machet L; Diot P; Rivollier C; Dumont P; Lorette G; Vaillant L
Ann Dermatol Venereol; 2005 Jan; 132(1):41-4. PubMed ID: 15746607
[TBL] [Abstract][Full Text] [Related]
27. A case of bullous disease limited to the skin illustrates the spectrum of neoplasia-induced autoimmunity.
Grover RK; Stites PC; Helm TN; Hashimoto T; Beutner EH
Dermatol Online J; 2009 Jul; 15(7):5. PubMed ID: 19903433
[TBL] [Abstract][Full Text] [Related]
28. Paraneoplastic Pemphigus in a 34-year-old.
Melnick LE; Beasley JM; Kim R; Brinster N; Sicco KL
Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447659
[TBL] [Abstract][Full Text] [Related]
29. Paraneoplastic pemphigus associated with fludarabine use.
Yildiz O; Ozguroglu M; Yanmaz MT; Turna H; Kursunoglu SG; Antonov M; Serdaroglu S; Demirkesen C; Buyukunal E
Med Oncol; 2007; 24(1):115-8. PubMed ID: 17673821
[TBL] [Abstract][Full Text] [Related]
30. Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy.
Lee S; Yamauchi T; Ishii N; Hashimoto T; Kinoshita K; Imamura S; Kamiya K
Int J Hematol; 2017 Dec; 106(6):852-859. PubMed ID: 28791608
[TBL] [Abstract][Full Text] [Related]
31. [A case of follicular lymphoma complicated with lethal pemphigus].
Imataki O; Tamai Y; Abe Y; Ito I; Yoshikawa S; Kawakami K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1677-80. PubMed ID: 17108741
[TBL] [Abstract][Full Text] [Related]
32. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
[TBL] [Abstract][Full Text] [Related]
33. Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue.
van der Waal RI; Pas HH; Anhalt GJ; Schulten EA; Jonkman MF; Nieboer C
Oral Oncol; 1998 Nov; 34(6):567-70. PubMed ID: 9930372
[TBL] [Abstract][Full Text] [Related]
34. Seeking approval: present and future therapies for pemphigus vulgaris.
Mao X; Payne AS
Curr Opin Investig Drugs; 2008 May; 9(5):497-504. PubMed ID: 18465660
[TBL] [Abstract][Full Text] [Related]
35. [Pemphigus: a review].
Joly P; Sin C
Ann Dermatol Venereol; 2011 Mar; 138(3):182-200. PubMed ID: 21397148
[TBL] [Abstract][Full Text] [Related]
36. Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone.
Martínez De Pablo MI; Iranzo P; Mascaró JM; Llambrich A; Baradad M; Herrero C
Acta Derm Venereol; 2005; 85(3):233-5. PubMed ID: 16040408
[TBL] [Abstract][Full Text] [Related]
37. Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature.
Barnadas M; Roe E; Brunet S; Garcia P; Bergua P; Pimentel L; Puig L; Francia A; García R; Gelpí C; Sierra J; Coll P; Alomar A
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):69-74. PubMed ID: 16405612
[TBL] [Abstract][Full Text] [Related]
38. Paraneoplastic pemphigus: a review of the literature.
Allen CM; Camisa C
Oral Dis; 2000 Jul; 6(4):208-14. PubMed ID: 10918557
[TBL] [Abstract][Full Text] [Related]
39. A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
Taintor AR; Leiferman KM; Hashimoto T; Ishii N; Zone JJ; Hull CM
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S73-6. PubMed ID: 17434044
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.
Doukaki S; Pistone G; Aricò M; Bongiorno MR
Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):237-44. PubMed ID: 21192770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
